Guggenheim Capital LLC Bluebird Bio, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $486,071 - $884,801	-54,249 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $144,366 - $269,724	12,844 Added 31.02%	54,249 $1.04 Million
Q2 2021 Aug 13, 2021	SELL	$18.04 - $22.09 $52,965 - $64,856	-2,936 Reduced 6.62%	41,405 $1.32 Million
Q1 2021 May 13, 2021	BUY	$16.59 - $33.89 $56,024 - $114,446	3,377 Added 8.24%	44,341 $1.34 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $68,942 - $95,065	-2,507 Reduced 5.77%	40,964 $1.77 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $298,388 - $379,050	-8,664 Reduced 16.62%	43,471 $2.35 Million
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $494,912 - $838,906	18,249 Added 53.85%	52,135 $3.18 Million
Q1 2020 Jun 02, 2020	SELL	$26.16 - $63.5 $194,708 - $472,630	-7,443 Reduced 18.01%	33,886 $1.56 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $431,609 - $566,808	9,191 Added 28.6%	41,329 $3.63 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $50,073 - $78,390	-842 Reduced 2.55%	32,138 $2.95 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $12,134 - $16,833	160 Added 0.49%	32,980 $4.2 Million
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $317,560 - $513,054	-4,928 Reduced 13.05%	32,820 $5.16 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $76,593 - $120,864	1,296 Added 3.56%	37,748 $3.75 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $578,478 - $764,859	6,510 Added 21.74%	36,452 $5.32 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $129,830 - $166,249	1,303 Added 4.55%	29,942 $4.7 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $174,464 - $248,900	1,649 Added 6.11%	28,639 $4.89 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $1.14 Million - $1.83 Million	-14,019 Reduced 34.19%	26,990 $4.81 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $2.37 Million - $3.75 Million	41,009	41,009 $5.63 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account